These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 9148861)

  • 21. Ovarian carcinoma cell cultures are resistant to TGF-beta1-mediated growth inhibition despite expression of functional receptors.
    Yamada SD; Baldwin RL; Karlan BY
    Gynecol Oncol; 1999 Oct; 75(1):72-7. PubMed ID: 10502429
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Levels of transforming growth factor beta and transforming growth factor beta receptors in rat liver during growth, regression by apoptosis and neoplasia.
    Grasl-Kraupp B; Rossmanith W; Ruttkay-Nedecky B; Müllauer L; Kammerer B; Bursch W; Schulte-Hermann R
    Hepatology; 1998 Sep; 28(3):717-26. PubMed ID: 9731564
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Relations of transforming growth factor-beta1 expression to differentiation and prognosis of advanced gastric cancer].
    Guo RF; Zang SZ; Zhang L; Li WM; Hu FL; Lü YY
    Zhonghua Yi Xue Za Zhi; 2006 Dec; 86(46):3249-54. PubMed ID: 17313802
    [TBL] [Abstract][Full Text] [Related]  

  • 24. BIGH3 is overexpressed in clear cell renal cell carcinoma.
    Yamanaka M; Kimura F; Kagata Y; Kondoh N; Asano T; Yamamoto M; Hayakawa M
    Oncol Rep; 2008 Apr; 19(4):865-74. PubMed ID: 18357369
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Analysis of the TGF beta functional pathway in epithelial ovarian carcinoma.
    Francis-Thickpenny KM; Richardson DM; van Ee CC; Love DR; Winship IM; Baguley BC; Chenevix-Trench G; Shelling AN
    Br J Cancer; 2001 Sep; 85(5):687-91. PubMed ID: 11531253
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Prohibitin suppresses renal interstitial fibroblasts proliferation and phenotypic change induced by transforming growth factor-beta1].
    Guo W; Xu H; Huang WY; Chen J; Yang Y; Fu R; Liu HM; Zha XL; Zhang ZG
    Zhonghua Yi Xue Za Zhi; 2007 Jun; 87(24):1660-5. PubMed ID: 17825142
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Study on the expression and mutation of cadherin 6 gene in human ovarian carcinoma].
    Li DR; Li L; Zhang W; Wang LM; Zhang JQ
    Zhonghua Fu Chan Ke Za Zhi; 2004 Sep; 39(9):616-9. PubMed ID: 15498191
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Transforming growth factor-beta 1 expression in epithelial ovarian neoplasms and its clinical significance].
    Huang XY; Wu YL; Liu FY
    Hunan Yi Ke Da Xue Xue Bao; 2002 Feb; 27(1):26-8. PubMed ID: 12575227
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Expression of TGF-beta 1 protein and mRNA and the effect on the tissue remodeling in laryngeal carcinomas.
    Hagedorn H; Sauer U; Schleicher E; Nerlich A
    Anticancer Res; 1999; 19(5B):4265-72. PubMed ID: 10628385
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Determination of transforming growth factor beta 1 mRNA expression in breast carcinomas by in situ hybridization.
    Walker RA; Gallacher B
    J Pathol; 1995 Oct; 177(2):123-7. PubMed ID: 7490677
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Expression of 72 kilodalton type IV collagenase (gelatinase A) in benign and malignant ovarian tumors.
    Autio-Harmainen H; Karttunen T; Hurskainen T; Höyhtyä M; Kauppila A; Tryggvason K
    Lab Invest; 1993 Sep; 69(3):312-21. PubMed ID: 8377473
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In situ distribution of transforming growth factor alpha in normal human tissues and in malignant tumours of the ovary.
    Kommoss F; Wintzer HO; Von Kleist S; Kohler M; Walker R; Langton B; Van Tran K; Pfleiderer A; Bauknecht T
    J Pathol; 1990 Nov; 162(3):223-30. PubMed ID: 2266459
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Overexpression of latent transforming growth factor-beta 1 (TGF-beta 1) binding protein 1 (LTBP-1) in association with TGF-beta 1 in ovarian carcinoma.
    Higashi T; Sasagawa T; Inoue M; Oka R; Shuangying L; Saijoh K
    Jpn J Cancer Res; 2001 May; 92(5):506-15. PubMed ID: 11376559
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Aromatase in human common epithelial ovarian neoplasms.
    Kaga K; Sasano H; Harada N; Ozaki M; Sato S; Yajima A
    Am J Pathol; 1996 Jul; 149(1):45-51. PubMed ID: 8686761
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The expression of Müllerian inhibiting substance/anti-Müllerian hormone type II receptor protein and mRNA in benign, borderline and malignant ovarian neoplasia.
    Song JY; Chen KY; Kim SY; Kim MR; Ryu KS; Cha JH; Kang CS; MacLaughlin DT; Kim JH
    Int J Oncol; 2009 Jun; 34(6):1583-91. PubMed ID: 19424576
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Molecular biology of human ovarian cancer.
    Chow SN; Chien CH; Chen CT
    Int Surg; 1996; 81(2):152-7. PubMed ID: 8912082
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Expression of transforming growth factors beta-1, beta 2 and beta 3 in human bladder carcinomas.
    Eder IE; Stenzl A; Hobisch A; Cronauer MV; Bartsch G; Klocker H
    Br J Cancer; 1997; 75(12):1753-60. PubMed ID: 9192977
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Elevated expression of ferritin H-chain mRNA in metastatic ovarian tumor.
    Tripathi PK; Chatterjee SK
    Cancer Invest; 1996; 14(6):518-26. PubMed ID: 8951356
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The prognostic value of epidermal growth factor receptor mRNA expression in primary ovarian cancer.
    Bartlett JM; Langdon SP; Simpson BJ; Stewart M; Katsaros D; Sismondi P; Love S; Scott WN; Williams AR; Lessells AM; Macleod KG; Smyth JF; Miller WR
    Br J Cancer; 1996 Feb; 73(3):301-6. PubMed ID: 8562334
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Expression profiling identifies altered expression of genes that contribute to the inhibition of transforming growth factor-beta signaling in ovarian cancer.
    Sunde JS; Donninger H; Wu K; Johnson ME; Pestell RG; Rose GS; Mok SC; Brady J; Bonome T; Birrer MJ
    Cancer Res; 2006 Sep; 66(17):8404-12. PubMed ID: 16951150
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.